Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200 | 159 | 4,666 | 11,367 | 12,253 |
| Marketable Securities | 8,571 | 9,829 | 6,017 | 3 | 78 |
| Other current assets | 70 | 69 | 67 | 66 | 0 |
| TOTAL | $8,921 | $10,178 | $10,955 | $11,572 | $12,912 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 66 | 68 | 69 | 71 | 137 |
| TOTAL | $66 | $68 | $69 | $71 | $137 |
| Total Assets | $8,987 | $10,246 | $11,024 | $11,643 | $13,049 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 607 | 1,048 | 660 | 364 | 240 |
| TOTAL | $679 | $1,120 | $732 | $436 | $312 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $812 | $830 | $848 | $866 | $884 |
| Total Liabilities | $1,491 | $1,950 | $1,580 | $1,302 | $1,196 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,109 | 3,109 | 3,159 | 3,159 | 3,139 |
| Retained earnings | -9,751 | -9,091 | -8,078 | -7,171 | -5,508 |
| Other shareholders' equity | -163 | -19 | 5 | 0 | 0 |
| TOTAL | $7,497 | $8,296 | $9,444 | $10,341 | $11,853 |
| Total Liabilities And Equity | $8,987 | $10,246 | $11,024 | $11,643 | $13,049 |